YIELD OF UNPREDICTED BONE-MARROW RELAPSE DIAGNOSED BY ROUTINE MARROW ASPIRATION IN CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKAEMIA. A Report from the Children's Cancer Study Group

Paul C.J. Rogers, Peter Coccia, Stuart Siegel, W. Archie Bleyer, John N. Lukens, Harland Sather, Denman Hammond

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

1466 children with acute lymphoblastic leukaemia had routine bone-marrow aspiration at the end of each 84-day cycle of maintenance therapy. Relapses detected by routine bone-marrow aspiration were classified according to whether or not they could be predicted by clinical signs or peripheral blood counts. In the low-risk, moderate-risk, and high-risk leukaemic patients 0 4%, 0·5%, and 0·8%, respectively, of the total routine bone-marrow aspirations yielded an unpredicted bone-marrow relapse. 19·4% of relapses were detected by routine surveillance marrow aspirations before any clinical signs of relapse on physical examination or peripheral blood count. The median survival after relapse in the predicted group was significantly shorter than that in the unpredicted group, but the eventual outcome was the same in both groups, 95% of all patients dying within 24 months of relapse.

Original languageEnglish (US)
Pages (from-to)1320-1322
Number of pages3
JournalThe Lancet
Volume323
Issue number8390
DOIs
StatePublished - Jun 16 1984

Fingerprint

Precursor Cell Lymphoblastic Leukemia-Lymphoma
Bone Marrow
Recurrence
Neoplasms
Physical Examination
Survival

ASJC Scopus subject areas

  • Medicine(all)

Cite this

YIELD OF UNPREDICTED BONE-MARROW RELAPSE DIAGNOSED BY ROUTINE MARROW ASPIRATION IN CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKAEMIA. A Report from the Children's Cancer Study Group. / Rogers, Paul C.J.; Coccia, Peter; Siegel, Stuart; Bleyer, W. Archie; Lukens, John N.; Sather, Harland; Hammond, Denman.

In: The Lancet, Vol. 323, No. 8390, 16.06.1984, p. 1320-1322.

Research output: Contribution to journalArticle

Rogers, Paul C.J. ; Coccia, Peter ; Siegel, Stuart ; Bleyer, W. Archie ; Lukens, John N. ; Sather, Harland ; Hammond, Denman. / YIELD OF UNPREDICTED BONE-MARROW RELAPSE DIAGNOSED BY ROUTINE MARROW ASPIRATION IN CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKAEMIA. A Report from the Children's Cancer Study Group. In: The Lancet. 1984 ; Vol. 323, No. 8390. pp. 1320-1322.
@article{0d4aadafcd184205b440c81db6c2287c,
title = "YIELD OF UNPREDICTED BONE-MARROW RELAPSE DIAGNOSED BY ROUTINE MARROW ASPIRATION IN CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKAEMIA. A Report from the Children's Cancer Study Group",
abstract = "1466 children with acute lymphoblastic leukaemia had routine bone-marrow aspiration at the end of each 84-day cycle of maintenance therapy. Relapses detected by routine bone-marrow aspiration were classified according to whether or not they could be predicted by clinical signs or peripheral blood counts. In the low-risk, moderate-risk, and high-risk leukaemic patients 0 4{\%}, 0·5{\%}, and 0·8{\%}, respectively, of the total routine bone-marrow aspirations yielded an unpredicted bone-marrow relapse. 19·4{\%} of relapses were detected by routine surveillance marrow aspirations before any clinical signs of relapse on physical examination or peripheral blood count. The median survival after relapse in the predicted group was significantly shorter than that in the unpredicted group, but the eventual outcome was the same in both groups, 95{\%} of all patients dying within 24 months of relapse.",
author = "Rogers, {Paul C.J.} and Peter Coccia and Stuart Siegel and Bleyer, {W. Archie} and Lukens, {John N.} and Harland Sather and Denman Hammond",
year = "1984",
month = "6",
day = "16",
doi = "10.1016/S0140-6736(84)91819-1",
language = "English (US)",
volume = "323",
pages = "1320--1322",
journal = "The Lancet",
issn = "0140-6736",
publisher = "Elsevier Limited",
number = "8390",

}

TY - JOUR

T1 - YIELD OF UNPREDICTED BONE-MARROW RELAPSE DIAGNOSED BY ROUTINE MARROW ASPIRATION IN CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKAEMIA. A Report from the Children's Cancer Study Group

AU - Rogers, Paul C.J.

AU - Coccia, Peter

AU - Siegel, Stuart

AU - Bleyer, W. Archie

AU - Lukens, John N.

AU - Sather, Harland

AU - Hammond, Denman

PY - 1984/6/16

Y1 - 1984/6/16

N2 - 1466 children with acute lymphoblastic leukaemia had routine bone-marrow aspiration at the end of each 84-day cycle of maintenance therapy. Relapses detected by routine bone-marrow aspiration were classified according to whether or not they could be predicted by clinical signs or peripheral blood counts. In the low-risk, moderate-risk, and high-risk leukaemic patients 0 4%, 0·5%, and 0·8%, respectively, of the total routine bone-marrow aspirations yielded an unpredicted bone-marrow relapse. 19·4% of relapses were detected by routine surveillance marrow aspirations before any clinical signs of relapse on physical examination or peripheral blood count. The median survival after relapse in the predicted group was significantly shorter than that in the unpredicted group, but the eventual outcome was the same in both groups, 95% of all patients dying within 24 months of relapse.

AB - 1466 children with acute lymphoblastic leukaemia had routine bone-marrow aspiration at the end of each 84-day cycle of maintenance therapy. Relapses detected by routine bone-marrow aspiration were classified according to whether or not they could be predicted by clinical signs or peripheral blood counts. In the low-risk, moderate-risk, and high-risk leukaemic patients 0 4%, 0·5%, and 0·8%, respectively, of the total routine bone-marrow aspirations yielded an unpredicted bone-marrow relapse. 19·4% of relapses were detected by routine surveillance marrow aspirations before any clinical signs of relapse on physical examination or peripheral blood count. The median survival after relapse in the predicted group was significantly shorter than that in the unpredicted group, but the eventual outcome was the same in both groups, 95% of all patients dying within 24 months of relapse.

UR - http://www.scopus.com/inward/record.url?scp=0021268483&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021268483&partnerID=8YFLogxK

U2 - 10.1016/S0140-6736(84)91819-1

DO - 10.1016/S0140-6736(84)91819-1

M3 - Article

C2 - 6145026

AN - SCOPUS:0021268483

VL - 323

SP - 1320

EP - 1322

JO - The Lancet

JF - The Lancet

SN - 0140-6736

IS - 8390

ER -